KoBioLabs, Inc (KOSDAQ: 348150)
South Korea
· Delayed Price · Currency is KRW 6,270.00
+70.00 (1.13%)
Sep 12, 2024, 9:51 AM KST
KoBioLabs Company Description
KoBioLabs, Inc. provides microbiome therapeutics for metabolic, immune, and neurological diseases. The company is based in Seongnam-si, South Korea.
KoBioLabs, Inc
| Country | South Korea |
| Industry | Biological Products, Except Diagnostic Substances |
| Employees | 50 |
| CEO | GwangPyo Ko |
Contact Details
Address: Building C Seongnam-si, 13488 South Korea | |
| Phone | 82 2 888 9964 |
| Website | kobiolabs.com |
Stock Details
| Ticker Symbol | 348150 |
| Exchange | KOSDAQ |
| Fiscal Year | January - December |
| Reporting Currency | KRW |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| GwangPyo Ko | Chief Executive Officer |
| Hyunkyu Lim | Chief Financial Officer |
| Han Seung Lee | Chief Operating Officer |